ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

RYZB RayzeBio Inc

62.49
0.00 (0.00%)
17 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
RayzeBio Inc RYZB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 62.49 09:00:00
개장가 저가 고가 종가 전일 종가
62.49 62.49
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/03/202406:07EDGAR2Form 15-12G - Securities registration termination [Section..
28/02/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/02/202423:20EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/02/202423:20EDGAR2Form 8-K - Current report
23/02/202421:53EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
23/02/202420:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
14/02/202423:19EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/02/202422:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/02/202420:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/02/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202422:53EDGAR2Form SC 14D9 - Solicitation, recommendation statements
09/01/202400:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
28/12/202306:15EDGAR2Form SC14D9C - Written communication relating to third party..
27/12/202307:08EDGAR2Form SC14D9C - Written communication relating to third party..
27/12/202300:28DJNTrending: Bristol Myers Squibb to Buy RayzeBio
26/12/202322:32EDGAR2Form SC14D9C - Written communication relating to third party..
26/12/202322:26EDGAR2Form 8-K - Current report
26/12/202322:04DJNRayzeBio Shares Soar Premarket on Takeover by Bristol Myers
26/12/202321:46DJNBristol Myers Squibb to Buy RayzeBio for $4.1 Billion
26/12/202321:13GLOBEBristol Myers Squibb Adds Premier Radiopharmaceutical..
26/12/202320:59BW Bristol Myers Squibb Adds Premier Radiopharmaceutical..
18/11/202308:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202308:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:03EDGAR2Form 8-K - Current report
14/11/202306:01GLOBERayzeBio Reports Third Quarter 2023 Financial Results and..
07/11/202306:05GLOBERayzeBio to Participate in Upcoming Investor Conferences in..
01/11/202322:14EDGAR2Form 8-K - Current report
01/11/202319:00GLOBERayzeBio Appoints Industry Leader Tim Van Hauwermeiren to..
24/10/202321:00GLOBEFDA selects RayzeBio to Participate in the Inaugural CDRP..
18/10/202320:00GLOBERayzeBio to Present at European Society for Medical Oncology..
20/09/202307:51KRMARKETNEWS인스타카트, 나스닥 데뷔로 주가는 12% 상승
20/09/202305:01BWRayzeBio, Inc. Announces Closing of Upsized $358 Million..